Caitong International Asset Management Co., LTD Rocket Pharmaceuticals, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 5,958 shares of RCKT stock, worth $62,380. This represents 0.07% of its overall portfolio holdings.
Number of Shares
5,958
Previous 5,958
-0.0%
Holding current value
$62,380
Previous $74.9 Million
-0.0%
% of portfolio
0.07%
Previous 0.07%
Shares
1 transactions
Others Institutions Holding RCKT
# of Institutions
243Shares Held
106MCall Options Held
268KPut Options Held
119K-
Rtw Investments, LP New York, NY17.7MShares$185 Million3.63% of portfolio
-
Wellington Management Group LLP Boston, MA14MShares$147 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$68.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$64.8 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$54.4 Million1.26% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $792M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...